Effect of Diaphragmatic Strengthening Exercises on Diaphragm Muscle Function in Patients With Post Covid-19 Syndrome.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-01

Study Completion Date

2023-02-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this work is to study the incidence of diaphragmatic dysfunction after COVID 19 infection and the efficacy of different types of diaphragmatic strengthening exercises on diaphragm muscle function.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Inspiratory Muscle Training in Post COVID-19 Patients

NCT04811859

Covid19 Infective Pneumonia

UNKNOWN NA

Manual Diaphragm Release on Stepping Reaction Time in Chronic Obstructive Pulmonary Disease

NCT06455033

Respiratory Disease

ACTIVE_NOT_RECRUITING NA

Influence of Manual Diaphragm Release on Pulmonary Functions in Women With COVID-19

NCT05903144

COVID-19 Pneumonia

COMPLETED NA

Respiratory Muscles After Inspiratory Muscle Training After COVID-19

NCT05582642

Diaphragm Injury COVID-19

COMPLETED NA

Effects of Inspiratory Muscle Training in Patients With Post COVID-19

NCT05231395

COVID-19

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Corona Virus Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

received, traditional medical treatment and no exercise

Group Type ACTIVE_COMPARATOR

Control

Intervention Type OTHER

Traditional medical treatment

diaphragmatic positioning group

received diaphragmatic strengthening exercises through patient self-positioning in prone on elbows then do diaphragmatic breathing 10-15 min ,twice/day, 7days/ weak

Group Type EXPERIMENTAL

diaphragmatic positioning

Intervention Type OTHER

Traditional medical treatment plus diaphragmatic strengthening exercises through patient self-positioning in prone on elbows then do diaphragmatic breathing 10-15 min ,twice/day, 7days/ weak

incentive spirometer group

received diaphragmatic strengthening exercises through using of incentive spirometer 10-15 min ,twice/day, 7days/ weak

Group Type EXPERIMENTAL

incentive spirometer

Intervention Type OTHER

Traditional medical treatment plus diaphragmatic strengthening exercises through using of incentive spirometer 10-15 min ,twice/day, 7days/ weak

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

diaphragmatic positioning

Traditional medical treatment plus diaphragmatic strengthening exercises through patient self-positioning in prone on elbows then do diaphragmatic breathing 10-15 min ,twice/day, 7days/ weak

Intervention Type OTHER

incentive spirometer

Traditional medical treatment plus diaphragmatic strengthening exercises through using of incentive spirometer 10-15 min ,twice/day, 7days/ weak

Intervention Type OTHER

Control

Traditional medical treatment

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female above 18 years old
* history of probable or confirmed SARS-CoV-2 infection 3 months from the onset of symptoms or at least 2 months from the end of symptoms .

Exclusion Criteria

* Subjects under 18.
* Patients known to have chronic lung disease .
* Patients known to have neuromuscular disorder.
* Patients known to have diaphragmatic hernia.
* Patients known to have malignancy.
* Patients with clinical evidence of phrenic nerve injury.
* Patients with recent abdominal or thoracic surgery,
* Patients with history of traumatic lesion possibly affecting diaphragm.
* Subjects with severe malnutrition.
* Patients with BMI more than 30

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No